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53 and the retinoblastoma (RB) pocket proteins are
central to the control of progression through the G1
phase of the cell cycle. The RB pocket protein family
is downstream of p53 and controls S-phase entry. Disruption
of actin assembly arrests nontransformed mammalian ﬁbro-
blasts in G1. We show that this arrest requires intact RB
pocket protein function, but surprisingly does not require
p53. Thus, mammalian ﬁbroblasts with normal pocket protein
function reversibly arrest in G1 on exposure to actin inhibitors
regardless of their p53 status. By contrast, pocket protein
triple knockout mouse embryo ﬁbroblasts and T antigen–
transformed rat embryo ﬁbroblasts lacking both p53 and
p
 
RB pocket protein function do not arrest in G1. Fibroblasts
are very sensitive to actin inhibition in G1 and arrest at
drug concentrations that do not affect cell adhesion or cell
cleavage. Interestingly, G1 arrest is accompanied by inhibi-
tion of surface rufﬂing and by induction of NF2/merlin. The
combination of failure of G1 control and of tetraploid
checkpoint control can cause RB pocket protein–suppressed
cells to rapidly become aneuploid and die after exposure
to actin inhibitors, whereas pocket protein–competent cells
are spared. Our results thus establish that RB pocket proteins
can be uniquely targeted for tumor chemotherapy.
 
Introduction
 
Both p53 and the retinoblastoma (RB)* pocket protein family
are central to the control of G1 progression in mammalian
cells. Between them, they can impose G1 arrest in response
to a multitude of stresses or signals, including DNA damage
(Kastan et al., 1991; Di Leonardo et al., 1994), polyploidization
(Cross et al., 1995; Minn et al., 1996; Lanni and Jacks,
1998; Andreassen et al., 2001b), depletion of nucleotide
pools (Linke et al., 1996), and TGF-
 
 
 
 (Polyak et al., 1994a;
Zhang et al., 1999). During G1 progression, p53 mediates
cell cycle arrest by transactivating specific targets. Among
these, the Cdk inhibitor (CKI) p21
 
WAF1
 
 acts to arrest the cell
cycle by inhibiting Cdk2/cyclin E and Cdk2/cyclin A (Dulic
et al., 1994). Suppression of Cdk activity blocks G1 progression
by regulating the phosphorylation status of the RB pocket
proteins (RB, p107, and p130), tumor suppressors of central
importance to the control of S-phase entry (Weinberg,
1995; Mittnacht, 1998; Mulligan and Jacks, 1998). Pocket
proteins are substrates for phosphorylation by G1 Cdks, and
once fully phosphorylated, they release E2F transcription
factors that permit progression from G1 to S phase (Dyson,
1998). The clear link between p53- and RB-dependent sup-
pression of the cell cycle in G1 is underlined by the fact that
abrogation of either RB pocket protein function or p53
function permits the cell cycle to continue after DNA damage
(Levine, 1997; Dannenberg et al., 2000; Sage et al., 2000).
RB pocket proteins appear to act downstream of p53 because
a normal p53 and p21
 
WAF1
 
 response occurs in cells deficient
for RB pocket protein function (Dannenberg et al., 2000; Sage
et al., 2000). In addition, p53 and the RB pocket protein family
cooperate in mediating G1 arrest in response to polyploidiza-
tion or exposure to inhibitors of mitotic spindle assembly (Di
Leonardo et al., 1997; Andreassen et al., 2001b; Borel et al.,
2002b). In contrast, as exemplified by G1 arrest of fibro-
blasts in response to the growth factor TGF-
 
 
 
, RB pocket
proteins can act independently of p53 (Zhang et al., 1999).
In addition to the intersection of the p53 and RB path-
ways, pocket protein suppression of G1 progression can be
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activated by CKIs, such as p27
 
Kip1
 
 and p16
 
INK4A
 
, that are in-
dependent of p53 control (Sherr and Roberts, 1995, 1999).
Given that the RB pocket protein pathway is believed to be
defective in nearly all human tumors (Weinberg, 1995;
Sherr, 1996; Hanahan and Weinberg, 2000), whereas p53
mutations are present in approximately half of human tu-
mors (Vogelstein et al., 2000), it is important to distinguish
RB-dependent suppression of the cell cycle that is clearly in-
dependent of the p53 pathway. The recent development of
mouse embryo fibroblast (MEF) cells with a knockout for all
three RB pocket proteins (RB, p107, and p130) in a back-
ground of normal p53 response now permits dissection of
such pocket protein–specific events.
Among the metabolic signals that the cell reads to enable
G1 progression is the status of the cytoskeleton. We have es-
tablished that stabilization of the microtubule array by taxol,
a drug inhibitor of microtubule dynamics, arrests nontrans-
formed fibroblasts in G1 in a p53-dependent manner (Tri-
elli et al., 1996; unpublished data). In addition, numerous
studies have shown that inhibition of actin assembly by
drugs of the cytochalasin family also suppresses G1 progres-
sion (Maness and Walsh, 1982; Iwig et al., 1995; Bohmer et
al., 1996; Huang et al., 1998; Reshetnikova et al., 2000),
and that arrest is abrogated by SV-40 transformation (Ma-
ness and Walsh, 1982).
As the SV-40 T antigen suppresses both p53 and RB
pocket protein function (Bargonetti et al., 1992; Zalvide et
al., 1998), we have here addressed whether the actin inhibi-
tion–dependent suppression of G1 progression is due to
p53- or RB pocket protein–specific signaling events. For
this, we have used mammalian cells containing either spe-
cific suppression of p53 or triple knockout of the RB pocket
proteins. We have also tested MEFs with a knockout of RB
alone or knockout of the alternative reading frame (ARF) tu-
mor suppressor that regulates p53 accumulation (Sherr and
Weber, 2000).
Strikingly, we demonstrate here that suppression of G1
progression in response to dihydrocytochalasin B (DCB) ex-
posure is dependent on the function of the RB pocket pro-
tein family, but not on p53 status. Moreover, RB pocket
protein–deficient cells also fail to undergo tetraploid check-
point arrest at concentrations of DCB that induce cleavage
failure (Andreassen et al., 2001b; Borel et al., 2002b). As a
result, RB pocket protein–deficient cells become highly
aneuploid after transient DCB exposure and rapidly die,
whereas p53-deficient cells efficiently arrest in G1. Our
work thus demonstrates that the RB pocket protein control
pathway has a unique capacity to control G1 progression af-
ter actin disruption that is clearly independent of the p53
pathway. Because there are functions specific to RB pocket
proteins that are independent of p53, our results show it
should be possible to selectively kill cells with RB pathway
defects. This may be important for therapeutic consider-
ations, given the nearly universal alterations of function of
the RB family pathway in tumor cells.
In addition, we have found in this work that pocket pro-
tein–competent G1 cells are extraordinarily sensitive to actin
inhibitors, arresting at concentrations that do not affect sub-
strate adhesion, cell spreading, or cell cleavage, but leave the
actin array largely undisturbed. This was a surprising result,
 
as the effect of actin assembly inhibition on G1 progression
had been linked to loss of cytoskeletal integrity and substrate
adhesion (Bohmer et al., 1996; Assoian and Zhu, 1997;
Reshetnikova et al., 2000). The question arises concerning
the control system in G1 that might be directly affected by
actin status. We have found that cell surface ruffling is spe-
cifically suppressed in cells arrested with low DCB concen-
trations. As the actin-associated ERM (ezrin, radixin, and
moesin) protein NF2/merlin has been implicated in both
cell surface ruffling (Bashour et al., 2002) and in suppression
of cell cycle progression in G1 (Shaw et al., 1998; Morrison
et al., 2001), we tested its status in arrested cells and found
that NF2/merlin is up-regulated in DCB-induced G1 arrest.
This result suggests that subtle cues from the actin cytoskele-
ton induce NF2/merlin-dependent arrest.
 
Results
 
DCB reversibly arrests mammalian fibroblasts in G1 
at concentrations that do not suppress cleavage
 
Actin inhibitors in the cytochalasin and latrunculin families
interfere with actin assembly and dynamics in mammalian
cells. At concentrations of DCB approaching 10 
 
 
 
M, the
suppression of actin assembly during late mitosis causes fail-
ure of cell cleavage (Aubin et al., 1981; Martineau et al.,
1995; Andreassen et al., 2001b), creating tetraploid cells.
Cytochalasins, at concentrations sufficient to fully disrupt
actin structures and block cytokinesis, also arrest nontrans-
formed cells in G1 (Bohmer et al., 1996; Assoian and Zhu,
1997; Reshetnikova et al., 2000). To establish the sensitivity
of cell cycle progression to actin disruption, we exposed
nontransformed REF-52 cells (primary rat embryo fibro-
blasts) in random cycle to different concentrations of DCB.
We found that cell proliferation was significantly suppressed
at 0.5 
 
 
 
M DCB and completely suppressed at concentra-
tions at or above 2 
 
 
 
M DCB (Fig. 1 A).
Surprisingly, we found that the lower drug concentrations
that suppressed cell cycle progression were significantly be-
low those that blocked cell cleavage, as demonstrated by
analysis of the DCB concentration–dependent induction of
binucleated cells (Fig. 1 B). Binucleated cells, indicative of
cleavage failure, did not appear at drug concentrations be-
low 4 
 
 
 
M. The combined effect of these different sensitivi-
ties on the status of cells after 24 h of drug exposure was to
create a population of 2N cells blocked in G1 at 2 
 
 
 
M
DCB, whereas higher DCB concentrations yielded cell pop-
ulations approximately equally divided between 2N and 4N
status (Fig. 1 C). The 4N cells arise from cleavage failure
and subsequent arrest in tetraploid G1, as we have previ-
ously shown (Andreassen et al., 2001b). These concentra-
tion-dependent profiles of cell cycle arrest were stable and
persisted for days (unpublished data). As a control, we show
that a concentration of nocodazole (0.5 
 
 
 
g/ml) sufficient to
fully disrupt microtubules did not arrest cells in G1 (Fig. 1
C). Cells instead progressed normally to mitotic arrest in the
same time course.
Arrest of the cell cycle in G1 is reversible. After 25 h expo-
sure to DCB, there is almost no DNA replication, as assayed
by BrdU incorporation. In contrast, after 2 h release from ei-
ther 2 or 10 
 
 
 
M DCB, mononucleate cells incorporatedT
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BrdU at levels comparable to controls that had not been ex-
posed to DCB (Fig. 1 D). Reentry into the cell cycle is re-
stricted to the mononucleate cells. As we have previously
shown (Andreassen et al., 2001b), nontransformed cells do
not recover from tetraploid G1 arrest. Thus, mononucleate
cells recover from 25 h exposure to 10 
 
 
 
M DCB and incor-
porate BrdU, whereas binucleate cells do not (Fig. 1 E).
Arrest of randomly cycling cells in G1 by low concentra-
tions of DCB is not restricted to REF-52 cells. Human non-
transformed IMR-90 fibroblasts show the same concentra-
tion-dependent sensitivity to DCB and arrest in 2N G1 when
exposed to 2 
 
 
 
M DCB, but arrest with approximately equal
2N and 4N status at higher DCB concentrations (Fig. 2 A). It
is important to note that the arrest in 2N G1 can be distin-
guished from the arrest of tetraploid cells with 4N DNA con-
tent after DCB exposure (Andreassen et al., 2001b).
 
Loss of p53 function does not affect G1 arrest
 
Previous work has established that SV-40 abrogates G1 ar-
rest by actin inhibition (Maness and Walsh, 1982). We also
found (Fig. 2 A) that T antigen–transformed REF-52
(TAG) showed no euploid cell cycle arrest during exposure
to DCB, nor did they arrest as tetraploid cells after cleavage
failure at 10 
 
 
 
M DCB (Fig. 2 A). SV-40 large T antigen has
multiple effects on the G1 cell cycle machinery and sup-
presses both p53- and RB pocket protein family–dependent
G1 controls (Bargonetti et al., 1992; Zhu et al., 1992; Zal-
vide et al., 1998). We next asked whether G1 arrest was de-
pendent on p53 or RB pocket protein status.
p53-dependent controls can be suppressed by expression
of a dominant-negative truncation mutant of p53 (p53DD)
(Shaulian et al., 1992). We have established a REF-52 cell
line (p53DD REF-52) that expresses dominant-negative
p53 (Andreassen et al., 2001b). To distinguish if p53 was in-
volved in DCB suppression of G1 progression, we exposed
p53DD REF-52 cells to both 2 and 10 
 
 
 
M DCB. Results
(Fig. 2 B) clearly demonstrate that DCB-dependent arrest in
G1 with 2N DNA content is independent of p53 function
as cells arrest equally in G1, regardless of p53 status. We
have obtained similar results with p53
 
 
 
/
 
 
 
 MEF cells (Fig. 3).
We conclude that p53 is not involved in the DCB-depen-
dent arrest of nontransformed fibroblasts in G1.
To confirm that the observed G1 arrest was specifically due
to suppression of actin dynamics, we exposed REF-52 cells to
latrunculin A, a compound that interferes with actin assembly
by sequestering actin subunits (Spector et al., 1989). Results
show that a low concentration of latrunculin A (0.2 
 
 
 
M)
blocks cells in G1, as evidenced by a decrease in S-phase cells
(Fig. 2 C), but does not interfere with cell cleavage, and thus
fails to augment the 4N population. By contrast, a higher
concentration (0.5 
 
 
 
M) yields approximately equal 2N and
4N populations (Fig. 2 C). As shown for DCB, TAG cells do
not arrest when exposed to latrunculin A. Similar results have
been obtained with cytochalasin D (unpublished data).
Figure 1. DCB induces reversible G1 
arrest of rat embryo fibroblasts (REF-52) 
at concentrations that do not block cell 
cleavage. (A) Increasing concentrations 
of DCB progressively suppress REF-52 
proliferation. Cells were exposed to the 
indicated DCB concentrations, and cell 
counts were taken at the indicated times. 
The curve is representative of three 
independent experiments. (B) DCB 
induces cytokinetic failure at 
concentrations  2  M. REF-52 cells 
were exposed to the indicated DCB 
concentrations for 25 h. Binucleate cells, 
indicative of cleavage failure, were 
counted. Bar graph incorporates data from 
three independent experiments (300–500 
cells counted each time). (C) DCB induces 
2N arrest at concentrations  4  M, 
whereas at higher concentrations, 
it yields both 2N and 4N arrest. REF-52 
cells were exposed to the indicated 
concentrations of DCB for 25 h and 
assayed by flow cytometry. Nocodazole 
exposure (0.5  g/ml) confirms that cells 
not treated with DCB were cycling in the 
same time course. (D) 2N G1 arrest 
imposed by DCB is reversible. REF-52 
cells were exposed to 2 or 10  M DCB 
for 25 h. Cells were then either maintained 
in DCB (spotted bars) or released from 
DCB (black bars) and exposed for 
another 25 h to 10  M BrdU to assay S-phase entry. BrdU incorporation was evaluated only in mononucleate cells. Values shown are the 
means of three independent counts of at least 300 cells each. (E) Binucleated cells do not recover from exposure to 10  M DCB. REF-52 cells 
were exposed to 10  M DCB for 25 h. DCB was then washed out, and cells were exposed to 10  M BrdU for 25 h. Mononucleate and 
binucleate BrdU-positive cells were independently counted. Values shown are means from three independent counts of 300 cells each.T
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Blockage by DCB in G1 is dependent 
on RB pocket proteins
 
REF-52 cells arrest in G1 in response to suppression of actin
dynamics even when p53 function is suppressed, but no ar-
 
rest occurs in REF-52 transformed with SV-40 large T anti-
gen (Fig. 2). As large T antigen suppresses the function of
both p53 and the RB family of pocket proteins, RB, p107,
and p130 (Bargonetti et al., 1992; Zalvide et al., 1998), the
implication is that suppression of actin dynamics may act
through the pocket proteins to block cells in G1.
To directly test the role of the RB pocket proteins in ac-
tin-dependent arrest in G1, we have compared the effect of
10 
 
 
 
M DCB on cell cycle progression in p53
 
 
 
/
 
 
 
 MEFs with
that in TKO MEFs, in which all three RB pocket proteins
have been deleted (Sage et al., 2000). As the three RB pocket
proteins have overlapping functions, deletion of all three is
necessary for immortalization of MEFs (Mulligan and Jacks,
1998; Dannenberg et al., 2000; Sage et al., 2000). After 24
h exposure to DCB, randomly cycling p53
 
 
 
/
 
 
 
 cells arrest
both in 2N G1 and in 4N G1 after cleavage failure (Fig. 3).
In contrast, TKO MEFs fail to arrest in 2N G1 but proceed
to a mixed 4N and 8N status (Fig. 3). We conclude that
suppression of actin assembly arrests MEFs in G1 through
the mediation of the RB pocket proteins, but not of p53.
In contrast to the differential effect of DCB on the cell cy-
cle in these MEF cell lines, nocodazole, which interferes
with microtubule dynamics and prevents completion of mi-
tosis (Jordan et al., 1992), has the same effect on both p53
 
 
 
/
 
 
 
and TKO MEFs. In both p53
 
 
 
/
 
 
 
 and TKO cell lines, 4N
and 8N populations predominate after 24 h of nocodazole
exposure (Fig. 3).
We obtained substantiating evidence for the role of the
RB pocket protein family in DCB-dependent arrest in G1
Figure 2. Actin inhibitors induce 
p53-independent 2N G1 arrest in 
nontransformed fibroblasts but not in 
transformed variants. (A) Nontransformed 
fibroblasts REF-52 and IMR-90, but not 
transformed TAG variants, arrest in the 
presence of DCB. REF-52, IMR-90, and 
TAG cells were exposed to the indicated 
concentrations of DCB for 25 h. Both 
REF-52 and IMR-90 arrest as 2N popu-
lations in the presence of DCB, whereas 
TAG cells do not arrest and progress to 
higher ploidy. Note that TAG cell cleavage 
is partially sensitive to 2  M DCB. (B) p53 
is not required for 2N G1 arrest in the 
presence of DCB. p53 was inactivated in 
REF-52 (p53DD) by expression of a 
dominant-negative mutant (Shaulian et al., 
1992; Andreassen et al., 2001b). p53
 /  
REF-52 and p53DD REF-52 cells were 
exposed to either 2 or 10  M DCB for 
25 h. Flow cytometry shows that p53DD 
REF-52 and control (p53
 / ) REF-52 
exhibit comparable 2N G1 arrest in the 
presence of DCB. (C) Latrunculin A 
imposes 2N G1 arrest in REF-52 cells but 
not in their transformed variants. REF-52 
and TAG cells were exposed to the 
indicated concentrations of latrunculin 
A for 25 h. Flow cytometry shows that 
REF-52 cells exhibit 2N G1 arrest both at 
0.2 and 0.5  M latrunculin A, whereas 
TAG cells do not arrest but progress to 
higher ploidy at 0.5  M latrunculin A.
Figure 3. DCB-induced G1 blockage is dependent on the RB 
pocket protein family. p53
 /  MEFs, MEFs deleted for the three RB 
pocket proteins (TKO), ARF
 /  MEFs, and RB
 /  MEFs were exposed 
to 10  M DCB or to nocodazole (0.5  g/ml) for 25 h and analyzed 
for cell cycle distribution. Flow cytometric analysis shows that 
p53
 /  MEFs exhibit 2N G1 arrest, whereas TKO MEFs do not and 
instead progress to higher ploidy. ARF
 /  MEFs exhibit 2N G1 arrest 
like that of p53
 /  MEFs, whereas RB
 /  MEFs exhibit partial 2N G1 
arrest unlike TKO MEFs, which do not arrest. In all cases, nocodazole 
exposure confirms that control cells, not exposed to DCB, were 
cycling in the same time course.T
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by also examining the response of RB
 
 
 
/
 
 
 
 and ARF
 
 
 
/
 
 
 
MEFs. Knockout of RB alone does not immortalize cells or
block contact inhibition arrest (Dannenberg et al., 2000;
Sage et al., 2000), as the RB protein family has overlapping
and redundant functions. RB
 
 
 
/
 
 
 
 cells, however, showed a
partial loss of arrest in G1 in response to DCB (Fig. 3). ARF
stabilizes p53 and is required for p53-dependent cell cycle
arrest, but is not required for the RB pocket protein control
in G1 (Sherr and Weber, 2000). As expected for a protein
that stabilizes p53 but does not influence the RB pathway,
knockout of ARF had no effect on the capacity of MEFs to
arrest in G1 when exposed to DCB (Fig. 3).
 
G1-arrested fibroblasts remain adherent but suppress 
ruffling and up-regulate NF2/merlin in 2 
 
 
 
M DCB
 
There is substantial evidence that the capacity of nontrans-
formed fibroblasts to progress in the cell cycle is coupled to sub-
stratum adherence (Stoker et al., 1968; Assoian, 1997; Assoian
and Schwartz, 2001). However, even at 10 
 
 
 
M DCB, we have
found that cells that are no longer capable of undergoing cleav-
age remain adherent (unpublished data). At 2 
 
 
 
M DCB, there
is little overt evidence of disturbance of the actin cytoskeleton in
randomly cycling interphase cells and no evidence of distur-
bance of adhesion (Fig. 4). Compared with controls, cells retain
abundant actin cables, and focal adhesion plaques appear intact,
as assayed by both vinculin antibody (Fig. 4 A) and antiphos-
photyrosine antibody (Fig. 4 B). One notable change during ar-
rest is that, in comparison to controls, cells exposed to 2 
 
 
 
M
DCB have smooth margins and do not appear to undergo ruf-
fling (Fig. 4 C). The absence of ruffling is rapidly reversible on
release from DCB, and ruffling is equally evident at 30 min and
a full day after DCB release (Fig. 4 C).
The absence of ruffling (Fig. 4) and the RB pocket protein
dependence of DCB G1 arrest induced by DCB (Fig. 3) sug-
gested a possible involvement of NF2/merlin as a mediator of
DCB-dependent arrest. Knockout of the RB pocket protein
family abolishes contact inhibition–dependent arrest (Dan-
nenberg et al., 2000; Sage et al., 2000). The tumor suppressor
NF2/merlin, an actin-binding protein (Gautreau et al., 2002)
that suppresses cell surface ruffling (Bashour et al., 2002), is
specifically up-regulated during, and is required for, contact
inhibition arrest in G1 (Shaw et al., 1998; Morrison et al.,
2001). We therefore assayed for the status of NF2/merlin in
G1 arrest induced by 2 
 
 
 
M DCB. Strikingly, we found that
NF2/merlin is strongly up-regulated and dephosphorylated in
DCB-dependent arrest in comparison to randomly cycling
cells (Fig. 4 D). This result suggests that NF2/merlin up-reg-
ulation may mediate the actin-dependent arrest.
Adherence to the substratum is intact in 2 
 
 
 
M DCB-
treated cells by the criterion of the activation of extracellular
signal–regulated kinase (ERK) on serum stimulation in the
presence of 2 
 
 
 
M DCB. Fibroblast cell lines maintained in
suspension fail to activate the ERK pathway in response to
growth factor stimulation (Lin et al., 1997; Renshaw et al.,
1997; Aplin et al., 1999). REF-52 cells arrest in G0 after se-
rum starvation, and 2 
 
 
 
M or 10 
 
 
 
M DCB, but not nocoda-
zole, inhibits progression past G1 upon serum add-back
(Fig. 5 A). In accord with previous findings (Reshetnikova et
al., 2000), we have found that REF-52 cells released from
 
G0 serum starvation in the presence of low concentrations
of DCB showed time-dependent ERK activation after serum
add-back that is indistinguishable from controls (Fig. 5 B).
Further, after serum stimulation, ERK migrates to the nuclei
of DCB-blocked cells (Fig. 5 C).
Our results indicating up-regulation of NF2/merlin during
DCB-induced arrest and the requirement for RB proteins
both suggested that arrest would be in G1. Further, Bohmer
et al. (1996) found, in timed experiments with synchronous
cells, that arrest of fibroblasts with high concentrations of cy-
tochalasin occurred in mid to late G1. To assess the physio-
logical status of randomly cycling cells arrested in G1 by 25 h
exposure to 2 
 
 
 
M DCB, we assayed for the presence and ac-
tivity of different cell cycle markers, compared with the pres-
ence of these markers in contact-inhibited cells in G0/G1, in
control cycling cells, or in cycling cells arrested in S phase
(Fig. 6). S-phase cells were obtained by exposure for 25 h to 2
mM hydroxyurea (HU), which blocks cells at the G1/S
Figure 4. Actin stress fibers and substratum adherence are not 
perturbed but NF2/merlin is up-regulated after exposure of REF-52 
cells to 2  M DCB. REF-52 cells were exposed to 2  M DCB for 
25 h. Cells were then analyzed for actin distribution with TRITC-
phalloidin (A and B, left), and vinculin (A, right) and phosphotyrosine 
(B, right) distribution were determined by immunolabeling. For each 
pair (untreated/DCB) in both A and B, the intensity settings used for 
confocal microscopy were kept constant. Bars, 40  m. (C) Higher 
magnification images show that ruffling was suppressed in cells 
exposed to 2  M DCB for 25 h (DCB), but reappeared rapidly 
(arrowheads) in cells released from DCB (30 min) and persisted at 
25 h of release. Cells were imaged for actin with TRITC-phalloidin. 
Bar, 40  m. (D) NF2/merlin is up-regulated and dephosphorylated 
in DCB-arrested cells. REF-52 cells, either random cycling (Rdom), 
contact inhibited (CI), or random cycling while exposed to 2  M 
DCB for 25 h (DCB), were harvested and subjected to Western 
blotting procedures using anti-NF2/merlin antibodies. An equivalent 
amount of protein was loaded for each sample.T
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boundary with active Cdk2 and suppressed p27 (Borel et al.,
2002a). The levels of different markers in DCB-arrested cells
resembled those found in contact-inhibited cells. Cyclin A
was absent in both cases, and p27
 
Kip1
 
, a CKI (Polyak et al.,
1994a,b), was elevated. p21
 
WAF1
 
, a CKI transactivated by p53
(el-Deiry et al., 1993), was not elevated, consistent with the
insensitivity of arrest to p53 status. RB was hypophosphory-
lated both in contact-inhibited cells and in DCB-treated
cells. This profile is consistent with suppression of Cdk2 ac-
tivity in both contact-inhibited and DCB-blocked status
(Fig. 6 B). In contrast to contact-inhibited cells, drug-
arrested cells showed reduced Cdk4 activity (Fig. 6 B). The
induction of p27
 
Kip1
 
 was not incidental to DCB treatment, as
 
it did not occur in cells that were first arrested in S phase with
HU and then treated with DCB (Fig. 6 C).
 
Cells with suppressed RB pocket protein function, 
but not with suppressed p53 function, die rapidly 
after DCB exposure
 
We, and others, have previously shown that a p53-dependent
G1 checkpoint prevents progression of mammalian fibro-
blasts to S phase when they have exited mitosis without com-
pleting chromosome segregation or cell cleavage (Minn et al.,
1996; Lanni and Jacks, 1998; Andreassen et al., 2001b). Fail-
ure to arrest in tetraploid G1 rapidly leads to aneuploidy and
is lethal for the majority of cells that do not arrest. It is clear
that TKO MEFs, in contrast to p53
 
 
 
/
 
 
 
 MEFs, fail to arrest in
either euploid or tetraploid G1 after exposure to DCB (Fig.
3). Thus, as found after suppression of p53 activity (Andreas-
sen et al., 2001b), suppression of RB pocket proteins can lead
to aneuploidy and death after induction of tetraploidy.
In the presence of DCB, p53 suppression does not abro-
gate G1 arrest, whereas pocket protein suppression does.
Thus, in a randomly cycling population exposed to DCB,
lethality will differ depending on whether the cells are sup-
pressed for p53 activity or for RB pocket protein activity.
RB pocket protein–suppressed cells can progress past G1
and past tetraploid G1, potentially leading to aneuploidy
and death. In contrast, p53-incompetent cells arrest in eu-
ploid G1 in DCB and can thus recover normally upon drug
release. In accord with this hypothesis, we have found that
both REF-52 and p53DD REF-52 cells recovered from
DCB arrest, seeded by those cells that had been arrested in
euploid G1 (Fig. 7, A and B). In contrast, TAG cells that ad-
ditionally suppress RB pocket protein activity rapidly be-
came aneuploid, as shown by a decrease in DNA content
Figure 5. DCB does not interfere with ERK 
kinase activation and nuclear translocation 
upon serum stimulation of quiescent cells. 
(A) Serum-starved REF-52 cells were 
reactivated with 10% FCS in the presence of 
2 or 10  M DCB. Flow cytometry shows that 
cells remain arrested in G1 25 h after release. 
Nocodazole exposure of cells in the absence 
of DCB indicates that control cells were 
cycling in the same time course. (B) ERK1/2 
is normally activated in the presence of 2  M 
DCB. At time intervals after add-back of 
serum to serum-starved REF-52, cells were 
harvested and subjected to Western blotting 
using either antibodies to total ERK or to 
activated phospho-ERK. Experiments were 
run either in the presence of 2  M DCB 
(DCB, bottom two strips) or absence of 
DCB (Control, top two strips). ST designates 
quiescent serum-starved controls. (C) ERK1/2 
is normally translocated to the nucleus in the 
presence of 2  M DCB. 1 h after serum 
add-back to serum-starved REF-52 cells, 
ERK1/2 kinases were immunolocalized using 
anti–pan ERK antibodies. Experiments were 
run either in the presence of 2  M DCB 
(DCB, right) or in the absence of DCB 
(Control, left). Nuclei were counterstained 
with propidium iodide (PI). Bars, 50  m.
Figure 6. DCB-arrested REF-52 cells 
have markers characteristic of G1. 
(A) Asynchronous cells (Rdom), contact-
inhibited cells (CI), and cells exposed for 
25 h to either 2  M DCB (DCB) or 2 mM 
HU (HU) were harvested and subjected 
to Western blotting procedures using the 
indicated antibodies. (B) The kinase 
activities of Cdk2 and Cdk4 were 
determined after immunoprecipitation 
of the kinases and incubation with 
histone H1 (Cdk2) or RB peptide (ckd4) 
as substrates. Autoradiographs of 
32P 
incorporation are shown (top strips) and 
compared with the kinase expression 
levels as determined by Western blotting 
(bottom strips). (C) p27
Kip1 accumulation 
is not incidental to DCB treatment. REF-52 cells were exposed for 
25 h to either 2 mM HU or 2  M DCB. Alternatively, cells were 
exposed to 2 mM HU for 25 h before addition of 2  M DCB for 25 h 
in the continuous presence of HU. Samples were subjected to Western 
blotting analysis using anti-p27
Kip1 antibodies.T
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and loss of identifiable 2N and 4N peaks in DNA histo-
grams, and died after release from DCB (Fig. 7, A and B)
 
.
 
Similarly, RB pocket protein–suppressed MEFs (TKO)
showed a highly reduced capacity to proliferate after tran-
sient exposure to DCB compared with control p53
 
 
 
/ 
MEFs (Fig. 7 C).
As our results suggested that short term exposure to actin
inhibitors might kill tumor cells, we directly tested this pos-
sibility by exposing the human tumor cell lines HeLa (cer-
vical adenocarcinoma), HCT116 (colon carcinoma), and
A427 (lung carcinoma) to DCB or cytochalasin D. Cells
were exposed for 24 h and then released from drug. Results
(Fig. 7 D) show that all three tumor cell lines fail to prolifer-
ate after drug exposure, and that they are uniformly more
sensitive to cytochalasin D than to DCB.
Discussion
Nontransformed mammalian fibroblasts arrest reversibly in
G1 when exposed to low concentrations of actin assembly
inhibitors. We have found that G1 arrest is not sensitive to
p53 status, but only occurs when RB pocket protein activity
is intact. This observation demonstrates RB pocket protein
control that is distinct from p53 mechanisms. Further, as it
is believed that RB function must be suppressed in one way
or another in all human tumors (Weinberg, 1995; Sherr,
1996; Hanahan and Weinberg, 2000), our results raise the
possibility that a therapeutic approach could exploit the con-
tinued cycling of tumor cells when the actin cytoskeleton, or
elements of an associated pathway, is disrupted, causing di-
rected death by selective response of pocket protein–sup-
pressed cells to toxic agents. Independence of this G1 arrest
from p53 is critical to the potential therapeutic effectiveness
of such an approach in tumors with deficiencies in the RB
pathway, but with normal p53 function.
The effective concentrations of actin inhibitors that induce
G1 arrest are well below the concentrations that globally sup-
press actin assembly, substrate adhesion, or cell cleavage.
Suppression is accompanied by expression of p27
Kip1, hypo-
phosphorylation of RB, and inhibition of surface ruffling.
Figure 7. Failure of DCB-induced G1 
blockage is lethal in RB pocket protein–
suppressed cells. (A) Asynchronous 
REF-52, p53DD REF-52, and TAG cells 
were exposed to 5  M DCB for 24 h. 
Flow cytometric analysis of DNA content 
at the indicated times shows that TAG 
cells rapidly become aneuploid upon 
release from DCB, whereas REF-52 and 
p53DD REF-52 cells recover from DCB 
arrest and reach contact inhibition after 
a few days. (B) Asynchronous REF-52, 
p53DD REF-52, and TAG cells were 
exposed to 5  M DCB for 24 h. DCB 
was then washed out and cell counts 
were taken at the times indicated. 
(C) Asynchronous p53
 /  and TKO MEFs 
were exposed to 10  M DCB for 25 h. 
DCB was then washed out and cell 
counts taken at the indicated times. 
(D) Asynchronous HeLa, HCT 116, and 
A427 cells were exposed to either 10  M 
DCB or 5  M cytochalasin D (Cyto D) 
for 24 h. The drug was then washed out 
and cell counts taken at the times 
indicated. Control refers to untreated cells. 
In all cases, plateaus at late times indicate 
approach to confluency except for TKO 
MEFs, which do not reach high density.T
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However, there appears to be no inhibition of ERK activation
under arrest conditions (Reshetnikova et al., 2000; Fig. 4).
G1 arrest due to RB pocket proteins but not p53
We have demonstrated that G1 arrest due to actin inhibition
is dependent on the presence of the RB pocket proteins but
is independent of p53. Previous work had demonstrated that
SV-40–transformed fibroblasts do not arrest in G1 upon ac-
tin inhibition (Maness and Walsh, 1982). As SV-40 large T
antigen suppresses both p53 and RB (Bargonetti et al.,
1992; Zalvide et al., 1998), the relative involvement of p53
and the pocket proteins in the G1 suppression remained un-
resolved. p53 activation arrests cells in G1 in response to
DNA damage, as well as a variety of cell cycle disturbances.
For example, it is involved in G1 arrest induced by taxol
(Trielli et al., 1996; Wahl et al., 1996) or by creation of tet-
raploidy after failure of mitosis or cell cleavage (Cross et al.,
1995; Minn et al., 1996; Lanni and Jacks, 1998; Andreassen
et al., 2001b). p53 thus clearly mediates G1 arrest indepen-
dent of DNA damage.
The interconnections between p53- and RB pocket pro-
tein–dependent controls in G1, coupled with the fact that the
RB pocket proteins are overlapping in function (Mulligan and
Jacks, 1998), have made it difficult to distinguish events in
G1 that are dependent on the RB pocket proteins but are in-
dependent of p53. The generation of triple knockouts of the
three RB pocket proteins in MEF cells has, for the first time,
permitted an analysis of pocket protein functions responsive
to the actin assembly state that are independent of p53.
G1 arrest and the actin cytoskeleton
It has been evident for a long time that mammalian fibro-
blasts arrest in G1 when exposed to concentrations of cy-
tochalasin sufficient to fully dismantle the actin network
(Maness and Walsh, 1982; Iwig et al., 1995; Bohmer et al.,
1996; Huang et al., 1998; Reshetnikova et al., 2000). The
interpretation has been that G1 arrest due to cytochalasin
derives from loss of cytoskeletal integrity, triggering a G1 ar-
rest similar to that observed after loss of substrate adhesion
(Assoian, 1997; Assoian and Schwartz, 2001). We have here
demonstrated that arrest of cells in G1 after inhibition of ac-
tin assembly surprisingly occurs at inhibitor concentrations
that do not interfere with cell spreading, formation of focal
adhesions, or normal cell cleavage. Thus, although it is evi-
dent that actin-dependent substrate adhesion is required for
cell cycle progression, our work clearly shows that this is a
precondition for the cytoskeleton-dependent signal process-
ing that permits G1 progression, and that arrest occurs after
much more subtle perturbation of the actin cytoskeleton
than previously appreciated.
The progression of fibroblasts through G1 is regulated by
the combination of growth factor activation and integrin-
mediated adhesion to the extracellular matrix (Howe et al.,
1998; Assoian and Schwartz, 2001). The activation path-
ways converge on ERK1/2, and adhesion-dependent G1
progression thus appears to require the joint regulation of
p42/p44 MAP kinase by integrins and growth factors. We
find that ERK has sustained activity and correctly translo-
cates to the nucleus despite stable G1 arrest in DCB, indi-
cating that the receptor tyrosine kinase and integrin path-
ways are both active in the blocked cells (Lin et al., 1997;
Renshaw et al., 1997). Interestingly, our results show that
ERK1/2 is indistinguishably activated in DCB-treated cells
compared with G1 controls, and thus indicate that sustained
ERK1/2 activation is not sufficient for G1 progression.
These results agree with prior results that suggested ERK ac-
tivation in cytochalasin-arrested cells (Reshetnikova et al.,
2000), and are interesting in light of evidence that sustained
ERK1/2 activity alone is not sufficient to drive G1 progres-
sion in suspended fibroblasts and that other attachment-
dependent factors are involved (Le Gall et al., 1998).
The activation of ERK is a central feature of anchorage-
dependent cell growth, and its activity may be related to RB
pocket protein control that is independent of p53. The in-
duction of cyclin D1 expression and the down-regulation of
the CKIs p21
WAF1 and p27
Kip1 are major targets of anchor-
age-dependent signaling in G1 (Assoian, 1997). ERK1/2 is
critical to induction of cyclin D1 expression (Lavoie et al.,
1996; Weber et al., 1997) and has been shown to be in-
volved in p27
Kip1 down-regulation (Rivard et al., 1999; Del-
mas et al., 2001). These events are, in turn, requisite for
activation of Cdk4/6 and Cdk2 cyclin-dependent kinases,
which, in turn, hyperphosphorylate RB (for review see Mitt-
nacht, 1998), ultimately permitting release of the E2F tran-
scription factors that activate S phase. Interestingly, we have
found that, whereas ERK1/2 are activated by phosphoryla-
tion and are properly translocated to the nucleus, cyclin D1
expression and Cdk4 activation are both reduced. In keep-
ing with mid-G1 arrest (Bohmer et al., 1996), Cdk2 is inac-
tive and p27
Kip1 is up-regulated. Perhaps as a result, RB re-
mains hypophosphorylated in DCB-blocked cells. It will be
interesting to pursue these observations further, to under-
stand how actin suppression can block the pathway that per-
mits RB hyperphosphorylation after ERK1/2 activation.
It is of substantial interest that NF2/merlin up-regulation
and hypophosphorylation accompany DCB-dependent G1
arrest (Fig. 3 D). NF2/merlin is a member of the ERM
(ezrin, radixin, and moesin) family of actin-binding proteins
that link the actin cytoskeleton to the cell cortex (Gautreau
et al., 2002). It is up-regulated by, and required for, contact
inhibition arrest in G1 (Shaw et al., 1998; Morrison et al.,
2001). Further, increased levels of expression correlate well
with suppressed cell surface ruffling (Bashour et al., 2002).
Our results thus suggest that NF2/merlin is involved in the
pathway that leads to G1 arrest in DCB. It is possible that
suppression of ruffling by DCB gives a false signal of cell–
cell contact, leading to the contact inhibition response. In
accord with this suggestion, the RB pocket protein family,
which is required for DCB arrest, has been directly impli-
cated in the contact inhibition response (Dannenberg et al.,
2000; Sage et al., 2000).
Comparison to other cytoskeleton-dependent arrest 
in G1
The state of the cytoskeleton influences G1 progression
through mechanisms other than actin-dependent suppres-
sion. We have previously shown that taxol, an inhibitor of
microtubule dynamics, reversibly arrests nontransformed fi-
broblasts in G1 (Trielli et al., 1996). Further, we have estab-
lished that the taxol-dependent arrest is suppressed in T an-T
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tigen–transformed cells (Trielli et al., 1996). Unlike DCB-
dependent G1 arrest, taxol-dependent arrest in G1 is p53
dependent (unpublished data).
Arrest with DCB in G1 can also be distinguished from the
G1 arrest that arises from creation of a tetraploid state by
DCB-dependent suppression of cell cleavage. Tetraploid G1
arrest is permanent, persisting after removal of DCB (An-
dreassen et al., 2001b), and unlike the DCB G1 block, is de-
pendent on p53 status (Andreassen et al., 2001b). Tetra-
ploid G1 arrest occurs regardless of the cause of tetraploidy
(Andreassen et al., 2001b) and appears to be the predomi-
nant cause of p53-dependent 4N arrest in colon carcinoma
cells after DNA damage (Andreassen et al., 2001a).
Implications for tumor therapy
A remarkable aspect of the DCB-dependent G1 arrest re-
ported here is that it is insensitive to p53 status, but sensitive
to the status of the RB pocket proteins. Only MEF cells that
have a triple knockout for the three RB pocket proteins fail
to arrest in G1 in response to DCB exposure. The result is
duplicated in TAG cells, which are large T antigen–trans-
formed REF-52. We have shown that p53DD REF-52 cells
respond like wild-type cells to DCB, but that TAG cells fail
to arrest. The major effects of large T antigen are to suppress
p53 and the RB pocket protein functions (Bargonetti et al.,
1992; Zalvide et al., 1998). It is therefore likely that TAG
cells fail to arrest, as in the case of TKO MEF cells, because
the RB pocket proteins are suppressed.
To our knowledge, this is the first evidence that a pharma-
cological approach can both selectively block cells with intact
RB function and permit induction of death in cells with
compromised function. The result has been striking. The fail-
ure of RB pocket protein–suppressed cells to arrest in G1 in
the presence of high concentrations of DCB causes them to
selectively continue to cycle to aneuploid status and die. We
have further demonstrated that DCB and cytochalasin D effi-
ciently kill human tumor cells of three different tissue origins.
Latrunculin and other actin inhibitors are being used in clini-
cal chemotherapy trials (Jordan and Wilson, 1998). It will
now be of primary importance to establish whether latruncu-
lin or other drugs will have a selective lethal effect on RB-sup-
pressed cells. As the RB pocket protein pathway is suppressed
in virtually all human tumors, this approach may hold sub-
stantial promise for selective tumor therapy.
We have demonstrated the effect of RB suppression on
progression to cell death after exposure to DCB alone. An
alternative approach that might prove highly effective would
be to use low doses of actin inhibitors accompanied by expo-
sure to ionizing radiation or taxol, to which cycling cells are
particularly sensitive (Iliakis, 1991; Trielli et al., 1996;
Blajeski et al., 2001). In this case, only RB-suppressed cells
would bypass G1 arrest and would be selectively vulnerable
to death induced by conventional tumor therapy.
Materials and methods
Cell culture and infection
REF-52 cells and their SV-40 large T antigen–transformed derivatives
(TAG) (Perry et al., 1992) were a gift from G.R. Stark (Cleveland Clinic,
Cleveland, OH). REF-52 primary cells were used at  35 passages. IMR-90
cells were obtained from Coriell Cell Repositories. p53DD REF-52 were
prepared as previously described (Andreassen et al., 2001b). p53
 /  MEFs
were generated as described by Borel et al. (2002b). TKO and RB
 /  MEFs
were a gift from J. Sage and T. Jacks (Massachusetts Institute of Technol-
ogy, Cambridge, MA). ARF
 /  MEFs were obtained from C. Sherr and M.
Roussel (St. Jude’s Children’s Hospital, Memphis, TN). MEFs were used at
no more than four passages. HeLa and A427 cells were obtained from the
American Type Culture Collection. HCT 116 cells were the gift of B. Vo-
gelstein (Johns Hopkins University, Baltimore, MD). Cell doubling times at
mid-log phase were 24 h for REF-52, p53DD REF-52, IMR-90, TKO MEFs,
p53
 /  MEFs, RB
 /  MEFs, and Arf
 /  MEFs and 18 h for TAG. All cells
were cultured as monolayers in DME (GIBCO BRL) supplemented with
10% FCS (Biological Industries). Cells were maintained in a humid incuba-
tor at 37 C in a 5% CO2 environment.
Cell treatment and synchronization
Randomly cycling cells were exposed to the indicated doses of DCB for
24 h. To assay for cell cycle progression during or after exposure to DCB,
cells were incubated with 10  M BrdU for 24 h. To synchronize REF-52
cells in G0, cells were cultured in medium containing 0.1% FCS for 24 h.
Serum-starved cells were then released from G0 by the addition of 10%
FCS, and DCB, as appropriate, was added 2 h before serum addition. To
induce contact inhibition, REF-52 cells were kept at confluency for 36 h.
To synchronize REF-52 cells in early S phase, randomly cycling cells
were incubated with 2 mM HU for 24 h. In all cases, drugs were added to
randomly cycling cells no earlier than 36 h after replating to allow for full
spreading before drug treatment. HU, DCB, and nocodazole were ob-
tained from Sigma-Aldrich. Latrunculin A was obtained from Molecular
Probes. HU was prepared as a 200 mM stock in DME containing 10% FCS.
DCB, latrunculin A, and nocodazole were prepared in DMSO as 10 mM, 2
mM, and 1 mg/ml stocks respectively. BrdU was prepared from a 10 mM
stock in DME.
Cell counts and flow cytometry
Randomly cycling REF-52 cells were incubated with the indicated doses of
DCB. Every 24 h, cells were harvested by trypsinization and resuspended
in 1  PBS, and cell counts were taken using a Neubauer hemacytometer.
To assess the impact of DCB or cytochalasin D on cell survival, cells were
exposed to drug for 24 h and then released, and counts were then taken
every 24 h. For flow cytometry, cells were trypsinized, collected by centrif-
ugation, and then fixed, stored, and analyzed as previously described (An-
dreassen et al., 2001b).
Assay of Cdk activity
To assay for Cdk2 and Cdk4 activities, cell lysates were prepared from ran-
dom cycling REF-52, contact-inhibited REF-52, or random cycling REF-52
exposed to 2  M DCB or 2 mM HU for 24 h. Cells were collected by
trypsinization, and preparation of lysates, immunoprecipitation, and radio-
immune assay for Cdk4 and Cdk2 were as described by Trielli et al. (1996)
and Andreassen and Margolis (1994), respectively.
Immunoblotting
Cell lysates were prepared for Western blots as described above for Cdk
activity assay. 10  g of whole cell lysates (25  g for cyclin D1 and RB)
was then resolved by PAGE, transferred to nitrocellulose or Immobilon
(RB) sheets, blocked with 5% nonfat milk in TNT buffer (25 mM Tris, pH
7.5, 150 mM NaCl, and 0.05% Tween 20), incubated overnight with pri-
mary antibodies, and then incubated with HRP-conjugated anti–rabbit or
anti–mouse IgG secondary antibodies for 1 h. Protein–antibody complexes
were detected by ECL (Pierce Chemical Co.). The primary antibodies used
were anti–cyclin A (1:5,000), anti–cyclin E (1:3,000), anti-Cdk2 (1:3,000)
(Brenot-Bosc et al., 1995), anti–cyclin D1 (HD11; 1:200), anti-Cdk4
(1:1,000), anti-p21
WAF1 (C-19; 1:2,000), anti-NF2/merlin (C-18; 1:200) (all
from Santa Cruz Biotechnology, Inc.), anti-p27
Kip1 (1:2,500; Transduction
Laboratories), anti-RB (1:500; BD Biosciences), anti–pan ERK (1:12,000;
Zymed Laboratories), and anti–dual phosphorylated ERK (V8031; 1:2,000;
New England Biolabs, Inc.). All primary antibodies, except for p21
WAF1,
were diluted in TNT buffer containing nonfat milk (1% for RB; 2% for
p27
Kip1 and ERK antibodies; 2.5% for cyclin A, cyclin E, cyclin D1, and
Cdk2; 5% for Cdk4; and 10% for NF2/merlin). All secondary antibodies
were diluted 1:5,000 (except for detection of RB [1:300] and cyclin D1
[1:2,500]) in TNT buffer (also containing 2.5% nonfat milk for detection of
cyclin A, cyclin E, cyclin D1, and ERK).
Immunofluorescence microscopy
For immunofluorescence microscopy, cells were grown on poly-D-lysine–
coated glass coverslips. To assay for cytokinetic failure in the presence ofT
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DCB, cells were fixed with methanol at  20 C for 10 min, microtubules
were labeled as previously described (Trielli et al., 1996), and nuclei were
stained by the addition of 0.5  g/ml propidium iodide. For quantification
of BrdU incorporation, cells were fixed and prepared with FITC-conjugated
anti-BrdU antibody as previously described (Andreassen et al., 2001b).
To assay for actin assembly and cell adhesion, randomly cycling cells
were exposed to 2  M DCB for 24 h as described above, fixed with 2%
paraformaldehyde in PBS, and incubated with antibodies as previously de-
scribed (Andreassen and Margolis, 1994). Monoclonal anti-vinculin and
anti-phosphotyrosine antibodies (Sigma-Aldrich) were diluted 500-fold.
F-actin was detected by a 30-min incubation at 37 C with TRITC-conju-
gated phalloidin (1:1,000) (Sigma-Aldrich). To assay for ERK localization,
cells were fixed and prepared as above, except for pretreatment for 1 h
with PBS containing 5% FCS and 1% BSA and then incubation with anti–
pan ERK for 1 h at 37 C.
After appropriate staining and washes in PBS, cells were observed using
an Optiphot II microscope (Nikon) attached to an MRC-600 laser scanning
confocal apparatus (Bio-Rad Laboratories). Images were treated with
Adobe Photoshop
®.
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